معرفی
Traci LaMoia is a Research Fellow in the Shulman Lab at the Yale School of Medicine, Department of Internal Medicine. Her work focuses on metabolic dysfunction, particularly in metabolic disorders like diabetes, heart failure, and lipid-related pathologies. She investigates mechanisms of drug action (e.g., SGLT2 inhibitors, metformin) and mitochondrial dysfunction in metabolic regulation.
Her research employs advanced methodologies like Q-Flux to study hepatic metabolic fluxes and explores cellular pathways such as calcium signaling, insulin receptor trafficking, and lipid-induced insulin resistance. Key findings include insights into hepatic steatosis, mitochondrial calcium uniporter roles, and novel therapeutic targets for Pompe disease.
LaMoia holds a BS from the University of Central Florida (2016). Her contributions span basic science and translational research, with publications in high-impact journals. She has been recognized for her postdoctoral research in Yale’s 2024 cohort.